Related Experiment Video

Updated: Aug 7, 2026

Revealing the Ferroptotic Phenotype of Medulloblastoma
04:01

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on: March 15, 2024

Ferroptosis Induction in Glioma by Calceolarioside A via Modulation of the PI3K/Akt/Nrf2 Pathway

Yongdong Liu1, Yufang Liu2, Aiwu Li3

  • 1Department of Pediatric Surgery, Qilu Hospital of Shandong University; Department of Pediatric Surgery, Weifang Peoples Hospital.

Journal of Visualized Experiments : Jove
|August 6, 2026
PubMed

Insights

This article corrects a previous publication. It ensures the accuracy of scientific data and research findings for better reproducibility.

Area of Science:

  • Scientific methodology
  • Research integrity

Background:

  • Ensuring the accuracy of published scientific research is crucial.
  • Corrections are necessary to maintain the integrity of the scientific record.

Purpose of the Study:

  • To correct errors in a previously published article.
  • To provide accurate information for the scientific community.

Main Methods:

  • A review of the original article was conducted.
  • Specific errors were identified and documented.

Main Results:

  • The article identifies and rectifies errors in the original publication.
  • Corrected information is provided to ensure data integrity.

Conclusions:

  • The correction enhances the reliability of the scientific literature.
  • Maintaining research integrity through accurate reporting is paramount.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...